Found: 5
Select item for more details and to access through your institution.
Prospects and Challenges for the Commercialization of Biosimilars: Perspectives from the EU, Japan, and the US.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 3, p. 79, doi. 10.5912/jcb751
- By:
- Publication type:
- Article
What the patent dance of the biosimilars act means for biosimilars.
- Published in:
- Journal of Commercial Biotechnology, 2014, v. 20, n. 4, p. 31, doi. 10.5912/jcb678
- By:
- Publication type:
- Article
Patents or patients: who loses?
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 9, p. 877, doi. 10.1038/nbt.3005
- By:
- Publication type:
- Article
USPTO guidance on patentable subject matter: Impediment to biotechnology innovation?
- Published in:
- Journal of Commercial Biotechnology, 2014, v. 20, n. 3, p. 38, doi. 10.5912/jcb664
- By:
- Publication type:
- Article
Evergreening patents: The Indian Supreme Court rejects patenting of incremental improvements.
- Published in:
- Journal of Commercial Biotechnology, 2013, v. 19, n. 3, p. 54, doi. 10.5912/jcb614
- By:
- Publication type:
- Article